APO Research
Talk to an analyst

APO RESEARCH · REPORT

HIV Supplemental Assays and Control Kit

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global HIV Supplemental Assays and Control Kit Industry Growth and Trends Forecast to 2032

24 December 202579 pages

Choose your research edition.

Industry ResearchHIV Supplemental Assays and Control Kit Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal HIV Supplemental Assays and Control Kit Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal HIV Supplemental Assays and Control Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HIV Supplemental Assays and Control Kit Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal HIV Supplemental Assays and Control Kit Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global HIV Supplemental Assays and Control Kit market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for HIV Supplemental Assays and Control Kit is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for HIV Supplemental Assays and Control Kit is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for HIV Supplemental Assays and Control Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of HIV Supplemental Assays and Control Kit include Hologic, Sedia Biosciences Corporation, INSTI and Bio-Rad Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global HIV Supplemental Assays and Control Kit market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The HIV Supplemental Assays and Control Kit market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global HIV Supplemental Assays and Control Kit market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to HIV Supplemental Assays and Control Kit.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global HIV Supplemental Assays and Control Kit market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

HIV Supplemental Assays and Control Kit Market by Company

Hologic

Sedia Biosciences Corporation

INSTI

Bio-Rad Laboratories

HIV Supplemental Assays and Control Kit Segment by Type

HIV-1 Test

HIV-2 Test

HIV Supplemental Assays and Control Kit Segment by Application

Hospital

Clinic

Others

HIV Supplemental Assays and Control Kit Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HIV Supplemental Assays and Control Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HIV Supplemental Assays and Control Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HIV Supplemental Assays and Control Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of HIV Supplemental Assays and Control Kit manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of HIV Supplemental Assays and Control Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of HIV-1 Test Table 2. Major Company of HIV-2 Test Table 3. Global HIV Supplemental Assays and Control Kit Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global HIV Supplemental Assays and Control Kit Sales by Type (2021-2026) & (K Units) Table 5. Global HIV Supplemental Assays and Control Kit Sales Market Share in Volume by Type (2021-2026) Table 6. Global HIV Supplemental Assays and Control Kit Sales by Type (2021-2026) & (US$ Million) Table 7. Global HIV Supplemental Assays and Control Kit Sales Market Share in Value by Type (2021-2026) Table 8. Global HIV Supplemental Assays and Control Kit Price by Type (2021-2026) & (US$/Unit) Table 9. Global HIV Supplemental Assays and Control Kit Sales by Type (2027-2032) & (K Units) Table 10. Global HIV Supplemental Assays and Control Kit Sales Market Share in Volume by Type (2027-2032) Table 11. Global HIV Supplemental Assays and Control Kit Sales by Type (2027-2032) & (US$ Million) Table 12. Global HIV Supplemental Assays and Control Kit Sales Market Share in Value by Type (2027-2032) Table 13. Global HIV Supplemental Assays and Control Kit Price by Type (2027-2032) & (US$/Unit) Table 14. North America HIV Supplemental Assays and Control Kit Sales by Type (2021-2026) & (K Units) Table 15. North America HIV Supplemental Assays and Control Kit Sales by Type (2021-2026) & (US$ Million) Table 16. Europe HIV Supplemental Assays and Control Kit Sales by Type (2021-2026) & (K Units) Table 17. Europe HIV Supplemental Assays and Control Kit Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific HIV Supplemental Assays and Control Kit Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific HIV Supplemental Assays and Control Kit Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America HIV Supplemental Assays and Control Kit Sales by Type (2021-2026) & (K Units) Table 21. Latin America HIV Supplemental Assays and Control Kit Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa HIV Supplemental Assays and Control Kit Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa HIV Supplemental Assays and Control Kit Sales by Type (2021-2026) & (US$ Million) Table 24. HIV Supplemental Assays and Control Kit Industry Trends Table 25. HIV Supplemental Assays and Control Kit Industry Drivers Table 26. HIV Supplemental Assays and Control Kit Industry Opportunities and Challenges Table 27. HIV Supplemental Assays and Control Kit Industry Restraints Table 28. Global HIV Supplemental Assays and Control Kit Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global HIV Supplemental Assays and Control Kit Revenue Market Share by Company (2021-2026) Table 30. Global HIV Supplemental Assays and Control Kit Sales by Company (2021-2026) & (K Units) Table 31. Global HIV Supplemental Assays and Control Kit Sales Share by Company (2021-2026) Table 32. Global HIV Supplemental Assays and Control Kit Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global HIV Supplemental Assays and Control Kit Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global HIV Supplemental Assays and Control Kit Major Company Production Sites and Headquarters Table 35. Global HIV Supplemental Assays and Control Kit Company, Product Type & Application Table 36. Global HIV Supplemental Assays and Control Kit Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global HIV Supplemental Assays and Control Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global HIV Supplemental Assays and Control Kit Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global HIV Supplemental Assays and Control Kit Sales by Region (2021-2026) & (K Units) Table 41. Global HIV Supplemental Assays and Control Kit Sales Market Share in Volume by Region (2021-2026) Table 42. Global HIV Supplemental Assays and Control Kit Sales by Region (2021-2026) & (US$ Million) Table 43. Global HIV Supplemental Assays and Control Kit Sales Market Share in Value by Region (2021-2026) Table 44. Global HIV Supplemental Assays and Control Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global HIV Supplemental Assays and Control Kit Sales by Region (2027-2032) & (K Units) Table 46. Global HIV Supplemental Assays and Control Kit Sales Market Share in Volume by Region (2027-2032) Table 47. Global HIV Supplemental Assays and Control Kit Sales by Region (2027-2032) & (US$ Million) Table 48. Global HIV Supplemental Assays and Control Kit Sales Market Share in Value by Region (2027-2032) Table 49. Global HIV Supplemental Assays and Control Kit Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global HIV Supplemental Assays and Control Kit Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global HIV Supplemental Assays and Control Kit Sales by Application (2021-2026) & (K Units) Table 52. Global HIV Supplemental Assays and Control Kit Sales Market Share in Volume by Application (2021-2026) Table 53. Global HIV Supplemental Assays and Control Kit Sales by Application (2021-2026) & (US$ Million) Table 54. Global HIV Supplemental Assays and Control Kit Sales Market Share in Value by Application (2021-2026) Table 55. Global HIV Supplemental Assays and Control Kit Price by Application (2021-2026) & (US$/Unit) Table 56. Global HIV Supplemental Assays and Control Kit Sales by Application (2027-2032) & (K Units) Table 57. Global HIV Supplemental Assays and Control Kit Sales Market Share in Volume by Application (2027-2032) Table 58. Global HIV Supplemental Assays and Control Kit Sales by Application (2027-2032) & (US$ Million) Table 59. Global HIV Supplemental Assays and Control Kit Sales Market Share in Value by Application (2027-2032) Table 60. Global HIV Supplemental Assays and Control Kit Price by Application (2027-2032) & (US$/Unit) Table 61. North America HIV Supplemental Assays and Control Kit Sales by Application (2021-2026) & (K Units) Table 62. North America HIV Supplemental Assays and Control Kit Sales by Application (2021-2026) & (US$ Million) Table 63. Europe HIV Supplemental Assays and Control Kit Sales by Application (2021-2026) & (K Units) Table 64. Europe HIV Supplemental Assays and Control Kit Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific HIV Supplemental Assays and Control Kit Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific HIV Supplemental Assays and Control Kit Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America HIV Supplemental Assays and Control Kit Sales by Application (2021-2026) & (K Units) Table 68. Latin America HIV Supplemental Assays and Control Kit Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa HIV Supplemental Assays and Control Kit Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa HIV Supplemental Assays and Control Kit Sales by Application (2021-2026) & (US$ Million) Table 71. Hologic Company Information Table 72. Hologic Business Overview Table 73. Hologic HIV Supplemental Assays and Control Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Hologic HIV Supplemental Assays and Control Kit Product Portfolio Table 75. Hologic Recent Development Table 76. Sedia Biosciences Corporation Company Information Table 77. Sedia Biosciences Corporation Business Overview Table 78. Sedia Biosciences Corporation HIV Supplemental Assays and Control Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sedia Biosciences Corporation HIV Supplemental Assays and Control Kit Product Portfolio Table 80. Sedia Biosciences Corporation Recent Development Table 81. INSTI Company Information Table 82. INSTI Business Overview Table 83. INSTI HIV Supplemental Assays and Control Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. INSTI HIV Supplemental Assays and Control Kit Product Portfolio Table 85. INSTI Recent Development Table 86. Bio-Rad Laboratories Company Information Table 87. Bio-Rad Laboratories Business Overview Table 88. Bio-Rad Laboratories HIV Supplemental Assays and Control Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Bio-Rad Laboratories HIV Supplemental Assays and Control Kit Product Portfolio Table 90. Bio-Rad Laboratories Recent Development Table 91. North America HIV Supplemental Assays and Control Kit Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. North America HIV Supplemental Assays and Control Kit Sales by Country (2021-2026) & (K Units) Table 93. North America HIV Supplemental Assays and Control Kit Sales Market Share by Country (2021-2026) Table 94. North America HIV Supplemental Assays and Control Kit Sales Forecast by Country (2027-2032) & (K Units) Table 95. North America HIV Supplemental Assays and Control Kit Sales Market Share Forecast by Country (2027-2032) Table 96. North America HIV Supplemental Assays and Control Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America HIV Supplemental Assays and Control Kit Market Size by Country (2021-2026) & (US$ Million) Table 98. North America HIV Supplemental Assays and Control Kit Market Share by Country (2021-2026) Table 99. North America HIV Supplemental Assays and Control Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America HIV Supplemental Assays and Control Kit Market Share Forecast by Country (2027-2032) Table 101. Europe HIV Supplemental Assays and Control Kit Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Europe HIV Supplemental Assays and Control Kit Sales by Country (2021-2026) & (K Units) Table 103. Europe HIV Supplemental Assays and Control Kit Sales Market Share by Country (2021-2026) Table 104. Europe HIV Supplemental Assays and Control Kit Sales Forecast by Country (2027-2032) & (K Units) Table 105. Europe HIV Supplemental Assays and Control Kit Sales Market Share Forecast by Country (2027-2032) Table 106. Europe HIV Supplemental Assays and Control Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe HIV Supplemental Assays and Control Kit Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe HIV Supplemental Assays and Control Kit Market Share by Country (2021-2026) Table 109. Europe HIV Supplemental Assays and Control Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe HIV Supplemental Assays and Control Kit Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific HIV Supplemental Assays and Control Kit Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific HIV Supplemental Assays and Control Kit Sales by Country (2021-2026) & (K Units) Table 113. Asia-Pacific HIV Supplemental Assays and Control Kit Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific HIV Supplemental Assays and Control Kit Sales Forecast by Country (2027-2032) & (K Units) Table 115. Asia-Pacific HIV Supplemental Assays and Control Kit Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific HIV Supplemental Assays and Control Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific HIV Supplemental Assays and Control Kit Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific HIV Supplemental Assays and Control Kit Market Share by Country (2021-2026) Table 119. Asia-Pacific HIV Supplemental Assays and Control Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific HIV Supplemental Assays and Control Kit Market Share Forecast by Country (2027-2032) Table 121. Latin America HIV Supplemental Assays and Control Kit Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Latin America HIV Supplemental Assays and Control Kit Sales by Country (2021-2026) & (K Units) Table 123. Latin America HIV Supplemental Assays and Control Kit Sales Market Share by Country (2021-2026) Table 124. Latin America HIV Supplemental Assays and Control Kit Sales Forecast by Country (2027-2032) & (K Units) Table 125. Latin America HIV Supplemental Assays and Control Kit Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America HIV Supplemental Assays and Control Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America HIV Supplemental Assays and Control Kit Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America HIV Supplemental Assays and Control Kit Market Share by Country (2021-2026) Table 129. Latin America HIV Supplemental Assays and Control Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America HIV Supplemental Assays and Control Kit Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa HIV Supplemental Assays and Control Kit Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa HIV Supplemental Assays and Control Kit Sales by Country (2021-2026) & (K Units) Table 133. Middle East and Africa HIV Supplemental Assays and Control Kit Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa HIV Supplemental Assays and Control Kit Sales Forecast by Country (2027-2032) & (K Units) Table 135. Middle East and Africa HIV Supplemental Assays and Control Kit Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa HIV Supplemental Assays and Control Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa HIV Supplemental Assays and Control Kit Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa HIV Supplemental Assays and Control Kit Market Share by Country (2021-2026) Table 139. Middle East and Africa HIV Supplemental Assays and Control Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa HIV Supplemental Assays and Control Kit Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. HIV Supplemental Assays and Control Kit Distributors List Table 144. HIV Supplemental Assays and Control Kit Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. HIV Supplemental Assays and Control Kit Image Figure 2. Global HIV Supplemental Assays and Control Kit Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HIV Supplemental Assays and Control Kit Market Size (2021-2032) & (US$ Million) Figure 4. Global HIV Supplemental Assays and Control Kit Sales (2021-2032) & (K Units) Figure 5. HIV-1 Test Image Figure 6. Global HIV-1 Test Sales YoY Growth (2021-2032) & (K Units) Figure 7. HIV-2 Test Image Figure 8. Global HIV-2 Test Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global HIV Supplemental Assays and Control Kit Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global HIV Supplemental Assays and Control Kit Market Share by Type 2025 VS 2032 Figure 11. North America HIV Supplemental Assays and Control Kit Sales Market Share in Volume by Type in 2025 Figure 12. North America HIV Supplemental Assays and Control Kit Sales Market Share in Value by Type in 2025 Figure 13. Europe HIV Supplemental Assays and Control Kit Sales Market Share in Volume by Type in 2025 Figure 14. Europe HIV Supplemental Assays and Control Kit Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific HIV Supplemental Assays and Control Kit Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific HIV Supplemental Assays and Control Kit Sales Market Share in Value by Type in 2025 Figure 17. Latin America HIV Supplemental Assays and Control Kit Sales Market Share in Volume by Type in 2025 Figure 18. Latin America HIV Supplemental Assays and Control Kit Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa HIV Supplemental Assays and Control Kit Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa HIV Supplemental Assays and Control Kit Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 HIV Supplemental Assays and Control Kit Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global HIV Supplemental Assays and Control Kit Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global HIV Supplemental Assays and Control Kit Market Share by Application 2025 VS 2032 Figure 31. North America HIV Supplemental Assays and Control Kit Sales Market Share in Volume by Application in 2025 Figure 32. North America HIV Supplemental Assays and Control Kit Sales Market Share in Value by Application in 2025 Figure 33. Europe HIV Supplemental Assays and Control Kit Sales Market Share in Volume by Application in 2025 Figure 34. Europe HIV Supplemental Assays and Control Kit Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific HIV Supplemental Assays and Control Kit Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific HIV Supplemental Assays and Control Kit Sales Market Share in Value by Application in 2025 Figure 37. Latin America HIV Supplemental Assays and Control Kit Sales Market Share in Volume by Application in 2025 Figure 38. Latin America HIV Supplemental Assays and Control Kit Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa HIV Supplemental Assays and Control Kit Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa HIV Supplemental Assays and Control Kit Sales Market Share in Value by Application in 2025 Figure 41. North America HIV Supplemental Assays and Control Kit Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America HIV Supplemental Assays and Control Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America HIV Supplemental Assays and Control Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America HIV Supplemental Assays and Control Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe HIV Supplemental Assays and Control Kit Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe HIV Supplemental Assays and Control Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe HIV Supplemental Assays and Control Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe HIV Supplemental Assays and Control Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific HIV Supplemental Assays and Control Kit Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific HIV Supplemental Assays and Control Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific HIV Supplemental Assays and Control Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific HIV Supplemental Assays and Control Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America HIV Supplemental Assays and Control Kit Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America HIV Supplemental Assays and Control Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America HIV Supplemental Assays and Control Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America HIV Supplemental Assays and Control Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa HIV Supplemental Assays and Control Kit Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa HIV Supplemental Assays and Control Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa HIV Supplemental Assays and Control Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa HIV Supplemental Assays and Control Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. HIV Supplemental Assays and Control Kit Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. HIV Supplemental Assays and Control Kit Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • HIV-1 Test
  • HIV-2 Test
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Hologic
  • Sedia Biosciences Corporation
  • INSTI
  • Bio-Rad Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global HIV Supplemental Assays and Control Kit Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global HIV Supplemental Assays and Control Kit Sales Estimates and Forecasts (2021-2032)
  5. 1.3 HIV Supplemental Assays and Control Kit Market by Type
  6. 1.3.1 HIV-1 Test
  7. 1.3.2 HIV-2 Test
  8. 1.4 Global HIV Supplemental Assays and Control Kit Market Size by Type
  9. 1.4.1 Global HIV Supplemental Assays and Control Kit Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global HIV Supplemental Assays and Control Kit Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global HIV Supplemental Assays and Control Kit Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America HIV Supplemental Assays and Control Kit Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe HIV Supplemental Assays and Control Kit Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific HIV Supplemental Assays and Control Kit Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America HIV Supplemental Assays and Control Kit Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa HIV Supplemental Assays and Control Kit Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 HIV Supplemental Assays and Control Kit Industry Trends
  2. 2.2 HIV Supplemental Assays and Control Kit Industry Drivers
  3. 2.3 HIV Supplemental Assays and Control Kit Industry Opportunities and Challenges
  4. 2.4 HIV Supplemental Assays and Control Kit Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by HIV Supplemental Assays and Control Kit Revenue (2021-2026)
  2. 3.2 Global Top Players by HIV Supplemental Assays and Control Kit Sales (2021-2026)
  3. 3.3 Global Top Players by HIV Supplemental Assays and Control Kit Price (2021-2026)
  4. 3.4 Global HIV Supplemental Assays and Control Kit Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global HIV Supplemental Assays and Control Kit Major Company Production Sites & Headquarters
  6. 3.6 Global HIV Supplemental Assays and Control Kit Company, Product Type & Application
  7. 3.7 Global HIV Supplemental Assays and Control Kit Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global HIV Supplemental Assays and Control Kit Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 HIV Supplemental Assays and Control Kit Players Market Share by Revenue in 2025
  11. 3.8.3 2025 HIV Supplemental Assays and Control Kit Tier 1, Tier 2, and Tier 3
4 HIV Supplemental Assays and Control Kit Regional Status and Outlook
  1. 4.1 Global HIV Supplemental Assays and Control Kit Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global HIV Supplemental Assays and Control Kit Historic Market Size by Region
  3. 4.2.1 Global HIV Supplemental Assays and Control Kit Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global HIV Supplemental Assays and Control Kit Sales in Value by Region (2021-2026)
  5. 4.2.3 Global HIV Supplemental Assays and Control Kit Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global HIV Supplemental Assays and Control Kit Forecasted Market Size by Region
  7. 4.3.1 Global HIV Supplemental Assays and Control Kit Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global HIV Supplemental Assays and Control Kit Sales in Value by Region (2027-2032)
  9. 4.3.3 Global HIV Supplemental Assays and Control Kit Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 HIV Supplemental Assays and Control Kit by Application
  1. 5.1 HIV Supplemental Assays and Control Kit Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global HIV Supplemental Assays and Control Kit Market Size by Application
  6. 5.2.1 Global HIV Supplemental Assays and Control Kit Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global HIV Supplemental Assays and Control Kit Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global HIV Supplemental Assays and Control Kit Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America HIV Supplemental Assays and Control Kit Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe HIV Supplemental Assays and Control Kit Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific HIV Supplemental Assays and Control Kit Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America HIV Supplemental Assays and Control Kit Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa HIV Supplemental Assays and Control Kit Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Hologic
  2. 6.1.1 Hologic Company Information
  3. 6.1.2 Hologic Business Overview
  4. 6.1.3 Hologic HIV Supplemental Assays and Control Kit Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Hologic HIV Supplemental Assays and Control Kit Product Portfolio
  6. 6.1.5 Hologic Recent Developments
  7. 6.2 Sedia Biosciences Corporation
  8. 6.2.1 Sedia Biosciences Corporation Company Information
  9. 6.2.2 Sedia Biosciences Corporation Business Overview
  10. 6.2.3 Sedia Biosciences Corporation HIV Supplemental Assays and Control Kit Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sedia Biosciences Corporation HIV Supplemental Assays and Control Kit Product Portfolio
  12. 6.2.5 Sedia Biosciences Corporation Recent Developments
  13. 6.3 INSTI
  14. 6.3.1 INSTI Company Information
  15. 6.3.2 INSTI Business Overview
  16. 6.3.3 INSTI HIV Supplemental Assays and Control Kit Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 INSTI HIV Supplemental Assays and Control Kit Product Portfolio
  18. 6.3.5 INSTI Recent Developments
  19. 6.4 Bio-Rad Laboratories
  20. 6.4.1 Bio-Rad Laboratories Company Information
  21. 6.4.2 Bio-Rad Laboratories Business Overview
  22. 6.4.3 Bio-Rad Laboratories HIV Supplemental Assays and Control Kit Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bio-Rad Laboratories HIV Supplemental Assays and Control Kit Product Portfolio
  24. 6.4.5 Bio-Rad Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America HIV Supplemental Assays and Control Kit Sales by Country
  2. 7.1.1 North America HIV Supplemental Assays and Control Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America HIV Supplemental Assays and Control Kit Sales by Country (2021-2026)
  4. 7.1.3 North America HIV Supplemental Assays and Control Kit Sales Forecast by Country (2027-2032)
  5. 7.2 North America HIV Supplemental Assays and Control Kit Market Size by Country
  6. 7.2.1 North America HIV Supplemental Assays and Control Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America HIV Supplemental Assays and Control Kit Market Size by Country (2021-2026)
  8. 7.2.3 North America HIV Supplemental Assays and Control Kit Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe HIV Supplemental Assays and Control Kit Sales by Country
  2. 8.1.1 Europe HIV Supplemental Assays and Control Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe HIV Supplemental Assays and Control Kit Sales by Country (2021-2026)
  4. 8.1.3 Europe HIV Supplemental Assays and Control Kit Sales Forecast by Country (2027-2032)
  5. 8.2 Europe HIV Supplemental Assays and Control Kit Market Size by Country
  6. 8.2.1 Europe HIV Supplemental Assays and Control Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe HIV Supplemental Assays and Control Kit Market Size by Country (2021-2026)
  8. 8.2.3 Europe HIV Supplemental Assays and Control Kit Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific HIV Supplemental Assays and Control Kit Sales by Country
  2. 9.1.1 Asia-Pacific HIV Supplemental Assays and Control Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific HIV Supplemental Assays and Control Kit Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific HIV Supplemental Assays and Control Kit Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific HIV Supplemental Assays and Control Kit Market Size by Country
  6. 9.2.1 Asia-Pacific HIV Supplemental Assays and Control Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific HIV Supplemental Assays and Control Kit Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific HIV Supplemental Assays and Control Kit Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America HIV Supplemental Assays and Control Kit Sales by Country
  2. 10.1.1 South America HIV Supplemental Assays and Control Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America HIV Supplemental Assays and Control Kit Sales by Country (2021-2026)
  4. 10.1.3 South America HIV Supplemental Assays and Control Kit Sales Forecast by Country (2027-2032)
  5. 10.2 South America HIV Supplemental Assays and Control Kit Market Size by Country
  6. 10.2.1 South America HIV Supplemental Assays and Control Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America HIV Supplemental Assays and Control Kit Market Size by Country (2021-2026)
  8. 10.2.3 South America HIV Supplemental Assays and Control Kit Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa HIV Supplemental Assays and Control Kit Sales by Country
  2. 11.1.1 Middle East and Africa HIV Supplemental Assays and Control Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa HIV Supplemental Assays and Control Kit Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa HIV Supplemental Assays and Control Kit Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa HIV Supplemental Assays and Control Kit Market Size by Country
  6. 11.2.1 Middle East and Africa HIV Supplemental Assays and Control Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa HIV Supplemental Assays and Control Kit Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa HIV Supplemental Assays and Control Kit Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 HIV Supplemental Assays and Control Kit Value Chain Analysis
  2. 12.1.1 HIV Supplemental Assays and Control Kit Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 HIV Supplemental Assays and Control Kit Production Mode & Process
  7. 12.2 HIV Supplemental Assays and Control Kit Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 HIV Supplemental Assays and Control Kit Distributors
  10. 12.2.3 HIV Supplemental Assays and Control Kit Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst